Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04997668 · ClinicalTrials.gov registry record · NA

Clinical Outcomes and Healthcare Economics of SOLTIVE Compared to Ho:YAG Laser in Urolithiasis

A NA study, sponsored by University of Kansas Medical Center.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT04997668 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04997668, a NA study, has completed, sponsored by University of Kansas Medical Center.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

To compare intraoperative as well as postoperative outcomes of SOLTIVE Thulium laser compared to Ho:YAG laser for the treatment of urolithiasis. The hypothesis is that utilizing the SOLTIVE Thulium laser for the treatment of urolithiasis will result in a more efficient procedure, with comparable stone free rate to that of Holmium laser and subjective improvement in physician satisfaction.

Interventions

  • DEVICE SOLTIVE Thulium Fiber Laser
  • DEVICE Ho:YAG Laser

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-09-01
Est. Completion 2026-03-25
Phase NA

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT04997668

The ClinicalTrials.gov registry entry for NCT04997668 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which SOLTIVE Thulium Fiber Laser is the first listed.

NCT04997668 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04997668 about?

NCT04997668 is a clinical study titled "Clinical Outcomes and Healthcare Economics of SOLTIVE Compared to Ho:YAG Laser in Urolithiasis". To compare intraoperative as well as postoperative outcomes of SOLTIVE Thulium laser compared to Ho:YAG laser for the treatment of urolithiasis. The hypothesis is that utilizing the SOLTIVE Thulium laser for the treatment of urolithiasis will result in a more efficient procedure, with comparable st...

What is the current status of trial NCT04997668?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2022-09-01. Estimated completion is 2026-03-25.

What interventions are being tested in trial NCT04997668?

The interventions under investigation include: SOLTIVE Thulium Fiber Laser (DEVICE), Ho:YAG Laser (DEVICE).

Who is sponsoring clinical trial NCT04997668?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.